Anixa Biosciences, Inc.
Anixa Biosciences, Inc., a pioneering biotechnology firm headquartered in the United States, focuses on innovative solutions in the fields of cancer immunotherapy and infectious disease. Founded in 2017, the company has rapidly established itself as a leader in developing cutting-edge therapies, particularly its unique approach to harnessing the immune system to combat cancer. With a strong emphasis on research and development, Anixa's core products include its proprietary CAR-T cell therapies and vaccine platforms, which are designed to provide targeted and effective treatment options. The company has achieved significant milestones, including collaborations with leading research institutions, positioning itself at the forefront of the biotechnology industry. Anixa Biosciences continues to drive advancements in healthcare, aiming to improve patient outcomes through its groundbreaking scientific innovations.
DitchCarbon Score
How does Anixa Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Anixa Biosciences, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Anixa Biosciences, Inc.'s reported carbon emissions
Anixa Biosciences, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete emissions figures or defined reduction strategies, it is challenging to assess their current environmental impact or commitments to climate action. However, as a company in the biotechnology sector, Anixa may be influenced by industry standards and practices regarding sustainability and emissions reduction. It is essential for companies in this field to adopt robust climate strategies to mitigate their environmental footprint and contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Anixa Biosciences, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
